Indian breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 11.1% during the forecast period. The major factors that are driving the market include the prevalence of breast cancer, awareness programs by government and private organizations in the country. Government agencies, NGOs and charity organizations have put great emphasis on improved breast cancer awareness among masses for promotion of early detection, providing comprehensive treatment module, providing support for breast cancer management and for screening and rehabilitation. The efforts have resulted in improved survival and quality of life of Indian breast cancer patients, however the improvement more pronounced in the urban population. The Extension for Community Healthcare Outcomes (ECHO) organizes breast cancer awareness and screening programs for rural and semi-urban Indian population. This project increased the cancer literacy amongst the rural population and awareness on early diagnosis of breast cancers and more public facilities for breast cancer treatments.
To Request a Sample of our Report on Indian Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/indian-breast-cancer-diagnostics-therapeutics-market
Indian breast cancer diagnostics and therapeutics market are segmented on the basis of cancer type, diagnostics, and therapeutics. In cancer type segment market is further classified into ductal carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics technology, the segment market is further classified into mammography, biopsy, position emission tomography/computed tomography, ultrasound, and others. The therapeutics technology segment market is further segregated into chemotherapy, hormone therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A full Report of Indian Breast Cancer Diagnostics And Therapeutics Market is Available @ https://www.omrglobal.com/industry-reports/indian-breast-cancer-diagnostics-therapeutics-market
Indian Breast Cancer Diagnostics And Therapeutics Market Segmentation
By Cancer Type
- Ductal Carcinoma In-Situ (DCIS)
- Invasive Ductal Carcinoma (IDC)
- Triple Negative Breast Cancer (TNBC)
- Inflammatory Breast Cancer
- Others (Invasive lobular carcinoma)
By Diagnostics
- Mammography
- Biopsy
- PET/CET
- Ultrasound
- Others (MRI)
By Therapeutics
- Chemotherapy
- Hormone Therapy
- Targeted Therapy
- Others (Radiation Therapy, Surgery)
Company Profiles
- AstraZeneca PLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis International AG
- F. Hoffmann-La Roche AG
- Sanofi S.A.
- Siemens Healthcare GmbH
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
